Subscription Price & Subscription Shares Allotment

RNS Number : 2902P
CC Japan Income & Growth Trust PLC
16 February 2021
 

16 February 2021

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, TO THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA   OR TO ANY NATIONAL, RESIDENT OR CITIZEN OF THE UNITED STATES, AUSTRALIA, NEW ZEALAND, CANADA, THE REPUBLIC OF SOUTH AFRICA, JAPAN OR ANY MEMBER STATE OF THE EEA

CC Japan Income & Growth Trust plc

 Subscription Price and Allotment of Subscription Shares

 

Subscription Price

In connection with the Bonus Issue of Subscription Shares to the Company's existing shareholders as detailed in the prospectus published by the Company on 22 January 2021 (the "Prospectus"), which was approved by Shareholders at the General Meeting held on 15 February 2021, the Board of Directors hereby announces the Subscription Price. Pursuant to the terms of the Bonus Issue as described in the Prospectus, the Subscription Price of the Subscription Shares is calculated as the unaudited published NAV per Ordinary Share (cum-income) as at close of business on 15 February 2021, plus a 1% premium to such NAV per Ordinary Share (cum-income), rounded up to the nearest whole penny. Accordingly, the Subscription Price payable on exercise of each Subscription Share has been calculated to be 161 pence.

 

Allotment of Subscription Shares

 

The Board has today allotted 26,946,122 Subscription Shares to Qualifying Shareholders whose names are entered on the register of members of the Company at 6.00 p.m. on 15 February 2021 (the "Record Date") pursuant to the terms of the Bonus Issue.  Application has been made for the admission of the Subscription Shares to the standard segment of the Official List and to trading on the main market of the London Stock Exchange. Dealings are expected to commence at 8.00 a.m. on 18 February 2021. Shareholders should note that, whilst the Record Date for the Bonus Issue was 6.00 p.m. on 15 February 2021, the ex-date for the Bonus Issue will be 18 February 2021 (the "Ex-Date"). Unless the counterparties specifically agree otherwise, a buyer of the Company's Ordinary Shares ahead of the Ex-Date will assume the benefit to the Subscription Shares, and the seller would need to pass the benefit to the buyer, even if the seller is the registered holder of such Ordinary Shares at the Record Date. Following admission of the Subscription Shares there will be 134,730,610 Ordinary Shares and 26,946,122 Subscription Shares in issue.

 

No Ordinary shares are held in treasury.

 

The dealing codes for the Subscription Shares will be as follows:

 

ISIN: GB00BM90B010

 

SEDOL: BM90B01

 

Ticker: CCJS

 

Capitalised terms used in this announcement shall have the same meaning ascribed to them in the Prospectus.

 

This announcement has been released on behalf of the Company by order of the Board.

 

The Company's LEI is: 549300FZANMYIORK1K98

 

Enquiries: 

Praxis IFM Fund Services (UK) Limited


Brian Smith / Ciara McKillop

020 4513 9260

Peel Hunt LLP

Luke Simpson / Liz Yong / Tom Pocock

020 7418 8900


This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America.  This announcement is not an offer of securities for sale into the United States.  The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEALAKFDLFEFA
UK 100

Latest directors dealings